Eli Lilly Urges 9th Circ. Not To Revive Cymbalta Suit

Law360, New York (August 23, 2016, 3:32 PM EDT) -- Eli Lilly and Co. on Monday urged the Ninth Circuit to affirm the denial of class certification and an injunction sought by three consumers accusing the pharmaceutical giant of failing to warn them of antidepressant Cymbalta's withdrawal risk.

Dr. Melissa Strafford, Carol Jacquez and David Matthews Jr. had argued in June that a California federal judge abused his discretion by ordering them to move for certification on their consumer protection law claims in four states without discovery, only to then turn around and conclude the consumers...
To view the full article, register now.